Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice

Metabolism ◽  
2004 ◽  
Vol 53 (11) ◽  
pp. 1473-1479 ◽  
Author(s):  
Mitsuo Tanimoto ◽  
Qiuling Fan ◽  
Tomohito Gohda ◽  
Toshihide Shike ◽  
Yuichiro Makita ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Early Stage ◽  
Type 2 Diabetic

Evaluation of urinary TNF-α and KIM-1 biomarkers in T2DM in Upper Egypt

QJM ◽  
2021 ◽  
Vol 114 (Supplement_1) ◽  
Author(s):  
Magdy EL Sharkawy ◽  
Samir K Abdul-Hamid ◽  
Tarek T Elmelegy ◽  
Mohammed F Adawy
Keyword(s):  
Diabetic Nephropathy ◽  
Early Stage ◽  
Clinical Syndrome ◽  
Diabetic Patients ◽  
University Hospitals ◽  
Type 2 Diabetic Patients ◽  
Cross Sectional ◽  
Tnf Α ◽  
Type 2 Diabetic

Abstract Background Diabetes mellitus (DM) is the most frequent cause of chronic kidney failure in both developed and developing countries. Diabetic nephropathy, is a clinical syndrome characterized by albuminuria (>300 mg/day) with permanent and irreversible decrease in glomerular filtration rate (GFR). Aim of the Work To study the role of urinary TNF-α and urine KIM-1 in type 2 diabetic patients as predictors of DN comparative with albuminuria. Patients and Methods This is a cross-sectional study which include 90 type-2 diabetic patients and 30 controls selected from the outpatient clinic of Assiut University hospitals. All patients gave an informed consent and approval for the study was obtained from the IRB committee of the Assiut Medical Faculty. The recruited patients were divided into three groups: Normo-albuminuria Group (A) (n = 30): UACR less than 30 mg/gm, Microalbuminuria Group (B) (n = 30): UACR between 30-299 mg/gm and Macro-albuminuria Group (C) (n = 30): UACR equal or more than 300 mg/gm. Assess Urinary TNF-α and urine KIM-1 in comparision with albuminuria. Results Urinary KIM-1 and urinary TNF-α are statically significant with albuminuria in patients in the early stage of diabetic nephropathy (eGFR _60 mL/min/1.73 m2).Also there are statically significance between patients with macroalbuminuria than microalbuminuria. Conclusion The results of this study recommend the use of KIM-1 and TNF-α as good predictors of early detection of development of diabetic nephropathy.

Nonalbumin proteinuria is a simple and practical predictor of the progression of early-stage type 2 diabetic nephropathy

2017 ◽  
Vol 31 (2) ◽  
pp. 395-399 ◽  
Author(s):  
Jong Ho Kim ◽  
Sang Soo Kim ◽  
In Joo Kim ◽  
Min Jin Lee ◽  
Yun Kyung Jeon ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Early Stage ◽  
Type 2 Diabetic

Fibroblast growth factor 21 as a predictor of early stage diabetic nephropathy in type 2 diabetic mellitus

2019 ◽  
Vol 22 (07) ◽  
pp. 01-07
Author(s):  
Samah Naji ◽  
Kareem Ghali ◽  
Najah Hadi ◽  
Maysaa Ali Abdul khaleq ◽  
Mohammed Abdelhussain
Keyword(s):  
Diabetic Nephropathy ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Early Stage ◽  
Fibroblast Growth Factor 21 ◽  
Fibroblast Growth ◽  
Diabetic Mellitus ◽  
Type 2 Diabetic Mellitus ◽  
Type 2 Diabetic

Plasma sRAGE is not associated with urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage

2010 ◽  
Vol 87 (2) ◽  
pp. 157-160 ◽  
Author(s):  
Jiang-Yi Yu ◽  
Xiao-Fei An ◽  
Jing-Shun Liu ◽  
Shi-Chao Ten ◽  
Xin Wang ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Early Stage ◽  
Type 2 Diabetic

scholarly journals Study of microalbuminuria as early risk marker of nephropathy in type 2 diabetic subjects

2017 ◽  
Vol 5 (7) ◽  
pp. 3161 ◽  
Author(s):  
Manish K. Verma ◽  
Pradeep Kumar ◽  
Preeti Sharma ◽  
V. K. Singh ◽  
Shashi Prabha Singh
Keyword(s):  
Diabetes Mellitus ◽  
Diabetic Nephropathy ◽  
Glycated Hemoglobin ◽  
Early Stage ◽  
Fasting Blood Glucose ◽  
Ion Exchange Resin ◽  
Risk Marker ◽  
Uncontrolled Diabetes ◽  
Type 2 Diabetic

 Background: Diabetic nephropathy (DN) is a common complication of diabetes mellitus that lead to end-stage of kidney disease (ESKD). Detection of early-stage can slow loss of kidney function and improve patient outcomes with use of diagnostic biomarker detection of DN. Aims and objectives of this study is to evaluate the possible association between glycated hemoglobin and urinary microalbumin as a predictor of diabetic nephropathy in type 2 diabetic patients.Methods: Total 162 subjects were included in this study comprises uncontrolled diabetes 54 cases, controlled diabetes 54 cases and healthy controlled 54 controls. Micro albumin was measured by urinary microalbumin (turbidimetric immunoassay), glycated hemoglobin (HbA1c) measured by ion exchange resin method and fasting blood glucose estimated by GOD-POD method. The inclusion of age group was between 35 to 74 years. Statistical analysis was done by using SPSS, version 16.0. p values were calculated by ANOVA unpaired t-test. The p<0.05 was considered a statistically significant.Results: Urinary microalbumin levels were statistically significant increase in type 2 diabetes mellitus with nephropathy in comparison to uncontrolled diabetes mellitus and controlled diabetes mellitus (138.9±13.7 mg/l vs 67.7±14.1 mg/l and p<0.005**).  HbA1c, which acts as a biomarker of diabetes was significant higher diabetic nephropathy, in comparison to uncontrolled diabetes mellitus, controlled diabetes mellitus and healthy control (8.0±1.1% vs 7.1±0.9% and 5.7±0.4%).Conclusions: The present study was demonstrated impaired glycaemic control is associated with elevations in urinary micro albumin levels and it may be considered as risk marker of diabetic nephropathy.

scholarly journals Plasma heparanase is associated with blood glucose levels but not urinary microalbumin excretion in type 2 diabetic nephropathy at the early stage

Renal Failure ◽  
2017 ◽  
Vol 39 (1) ◽  
pp. 698-701 ◽  
Author(s):  
Yue Zhao ◽  
Jingshun Liu ◽  
Shichao Ten ◽  
Jisheng Zhang ◽  
Yanggang Yuan ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Blood Glucose ◽  
Early Stage ◽  
Glucose Levels ◽  
Blood Glucose Levels ◽  
Type 2 Diabetic

scholarly journals Glomerular Hyperfiltration With Hyperglycemia in the Spontaneously Diabetic Torii (SDT) Fatty Rat, an Obese Type 2 Diabetic Model

2021 ◽  
pp. 45-54
Author(s):  
R SANO ◽  
Y ISHII ◽  
M YAMANAKA ◽  
Y YASUI ◽  
Y KEMMOCHI ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Kidney Diseases ◽  
Early Stage ◽  
Experimental Period ◽  
Glomerular Hyperfiltration ◽  
Histopathological Analysis ◽  
Good Glycemic Control ◽  
Diabetic Model ◽  
Type 2 Diabetic

Glomerular hyperfiltration is observed in an early stage of kidney diseases including diabetic nephropathy. A better understanding of pathophysiological changes in glomerular hyperfiltration is essential for development of new therapies to prevent kidney disease progression. In this study, we investigated glomerular changes including glomerular filtration rate (GFR) and glomerular size in the Spontaneously Diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model, and we also evaluated pharmacological effects of the sodium glucose cotransporter 2 inhibitor dapagliflozin on the renal lesions. Dapagliflozin was administered to SDT fatty rats from 5 to 17 weeks of age. Blood and urinary biochemical parameters were periodically measured. GFR was determined by transdermal GFR monitor at 16 weeks of age and histopathological analysis was performed at 17 weeks of age. SDT fatty rat developed severe hyperglycemia and exhibited pathophysiological abnormalities in the kidney, such as an increased GFR, glomerular hypertrophy and tissue lesions. Dapagliflozin achieved good glycemic control during the experimental period, inhibited the increase in GFR, and improved histopathological abnormalities in tubules. These results suggest that the SDT fatty rat is a useful model for analyzing the pathogenesis of diabetic nephropathy during its early stage and dapagliflozin improves not only hyperglycemia but also glomerular hyperfiltration and tubule lesions in SDT fatty rat.

Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKAy/Ta mice: involvement of anti-inflammation and antioxidative stress

Metabolism ◽  
2006 ◽  
Vol 55 (12) ◽  
pp. 1590-1598 ◽  
Author(s):  
Minfang Zhang ◽  
Shinji Hagiwara ◽  
Masukazu Matsumoto ◽  
Leyi Gu ◽  
Mitsuo Tanimoto ◽  
...  
Keyword(s):  
Diabetic Nephropathy ◽  
Eicosapentaenoic Acid ◽  
Early Stage ◽  
Antioxidative Stress ◽  
Type 2 Diabetic ◽  
Anti Inflammation

scholarly journals Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy

2021 ◽  
Author(s):  
Kadriye Akpınar ◽  
Diler Aslan ◽  
Semin Melahat Fenkçi
Keyword(s):  
Diabetic Nephropathy ◽  
Cystatin C ◽  
Early Stage ◽  
Roc Curves ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Male Age ◽  
Urine Albumin ◽  
Type 2 Diabetic

Abstract Introduction: GFR is estimated by using creatinine and cystatin C to determine renal dysfunction. Our aim was to evaluate estimated GFR (eGFR) based on cystatin C in type 2 diabetic patients with diabetic nephropathy (DN). Methods: Study group included 52 controls (46% male, age: 54.5±12.4) and 101 diabetic patients (46.5% male, age: 58.2±11). The diabetics were divided into three subgroups according to 24-hour urine albumin: normal to mildly increased (A1) (n=51), moderately increased (A2) (n=25), severely increased (A3) (n=25) albuminuria. Creatinine clearance (CrCl) was determined. Correlations between CrCl and eGFRs estimated according to the CKD-EPI, MDRD, and Cockcroft-Gault (CG) formulas, and ROC curves were evaluated. Data were analyzed using SPSS 22.0. Results: Only CKD-EPI-cys eGFR was significantly lower in the A1 group than the controls (p=0.021). All GFRs were lower in the A3 group than the control (CKD-EPI-cr, MDRD, CKD-EPI-cys, CKD-EPI-cr-cys: p=0.0001, CG and CrCl: p=0.001) and A1 (for all GFRs p=0.0001) groups. CKD-EPI-cr (p=0.004), MDRD (p=0.01), CG (p=0.037), CKD-EPI-cys (p=0.033), and CKD-EPI-cr-cys (p=0.016) eGFRs in the A2 group were significantly different from the A1 group. All eGFRs showed a moderate correlation with CrCl in the A1group (CKD-EPI-cr and CKD-EPI-cr-cys: r=0.49, p=0.0001, MDRD: r=0.44, p=0.001, CG r=0.48, p=0.0001: CKD-EPI-cys r=0.40, p=0.004). The area under the CKD-EPI-cys ROC curve was the highest and found to be 0.847 (95%CI 0.763-0.931, p=0.0001). Conclusions: Our results showed that the CKD-EPI-cys eGFR can be useful in detecting the early stage of DN and more predictive than the others for prediction of DN.

Sign in / Sign up

Export Citation Format

Share Document